南華早報

Drug maker Rohto plans clinical trials in Hong Kong as OASES’ first Japan partner

作者 Elizabeth Cheung全文約 3,902 字

文章摘要

南華早報 · 文章頁摘要

Firm’s chairman Kunio Yamada says city’s university research strength and proximity to mainland China are key draws.

Drug maker Rohto plans clinical trials in Hong Kong as OASES’ first Japan partner（新聞配圖）
配圖來源：南華早報

Top university research, cross-border data exchanges and access to mainland China’s large market have attracted Japanese firm Rohto Pharmaceutical to...

https://www.scmp.com/news/hong-kong/hong-kong-economy/article/3372885/drug-maker-rohto-plans-clinical-trials-hong-kong-oases-first-japan-partner